Navigation Links
CLAAD Recognizes SMART/Script as Top 5 Technology To Reduce Rx Abuse
Date:11/27/2012

WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- The Center for Lawful Access and Abuse Deterrence (CLAAD) today honored Atlantic Pharmaceuticals' SMART/Script as one of its "Top 5 Technologies To Reduce Prescription Drug Abuse."

Still in investigational stages, the SMART/Script technology is intended to deliver immediate- and extended-release opioid medications in a tamper-resistant form. If a medication formulated with SMART/Script were crushed or chewed, the SMART/Script technology would potentially prevent or slow the release of the active ingredient.

"We are honored to have our SMART/Script formulation system recognized by CLAAD and Millennium Laboratories," said Anthony Soscia, President of Atlantic Pharmaceuticals. "We believe that utilization of the SMART/Script platform will have a meaningful impact on prescription drug abuse."

The Top 5 Technologies competition aims to increase awareness of the U.S. prescription drug abuse epidemic, and to support private-sector efforts to address the problem.

Michael Barnes, spokesman for CLAAD, stated, "We support Atlantic Pharmaceuticals and other companies working to make medications less susceptible to abuse."

San Diego-based Millennium Laboratories co-sponsored the Top 5 Technologies contest.  Millennium provides medication monitoring, drug detection and pharmacogenetic testing services.

"We are proud to recognize Atlantic Pharmaceuticals for joining Millennium and CLAAD in our efforts to advance patient care and reduce prescription drug abuse," said Howard Appel, President of Millennium Laboratories. 

About the Center for Lawful Access and Abuse Deterrence
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) is a coalition of health care providers, law enforcement, community organizations, and businesses working together to reduce prescription drug abuse while optimizing patient care.  CLAAD's National Prescription Drug Abuse Prevention Strategy identifies the adoption of new technologies as an essential component of prescription drug abuse prevention policy.  Visit claad.org, and follow @claad_coalition. 

About Millennium Laboratories
Millennium Laboratories is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. The company provides healthcare professionals with medication monitoring, drug detection and pharmacogenetic testing services to personalize treatment plans to improve clinical outcomes and patient safety. 

About Atlantic Pharmaceuticals, Inc.
Atlantic Pharmaceuticals is a specialty pharmaceutical company developing technologies to increase the difficulty of tampering with orally administered immediate and sustained release pharmaceuticals. The company is using its proprietary SMART/Script (SMART/Simple, controllable, resistant, insoluble, physical trap) platform to formulate ATLP-02, a tamper resistant, immediate release, orally delivered oxycodone dosage form.


'/>"/>
SOURCE CLAAD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse
2. CLAAD Names Eagle Advancement Institute as Honoree of Top 5 Technologies To Reduce Prescription Drug Abuse
3. CLAAD Warns of Increase in Prescription Drug Overdoses
4. MinuteClinic Recognizes National Nurse Practitioner Week and Invests in the Education and Advancement of Clinicians Across the U.S.
5. CareFusion Recognizes Best Of The Best U.S. Hospitals
6. Frost & Sullivan Recognizes Terso Solutions, Inc. with 2012 Best Practices Award
7. Frost & Sullivan Recognizes Rosetta Genomics for Its Strategic Excellence and Strong Contribution to Next-Generation Diagnostics
8. Frost & Sullivan Recognizes Secant Medical as a Key Technology Enabler for Medical Implantable Textile Structures Design
9. Frost & Sullivan Recognizes Siemens Healthcares CT Imaging Solution for the Value it Offers Both Service Providers and Patients
10. Veteran-Owned Wiley X,® Inc. Recognizes Americas Heroes
11. Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 2016 --> ... Inflammation Global Clinical Trials Review, H2, 2015 provides ... clinical trials landscape along with top level data ... (G7 & E7), Trial Status, Trial Phase, Sponsor ... companies involved and enlists all trials (Trial title, ...
(Date:2/11/2016)... PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results ... The Company also filed its Quarterly Report on Form 10-Q ... Securities and Exchange Commission today. --> ... --> --> Net sales for the ... 95%, to $5.4 million from $2.8 million for the three ...
(Date:2/11/2016)... , Feb. 11, 2016  Governor Andrew M. ... will create 1,400 jobs throughout Western New ... partnership with the SUNY Polytechnic Institute, includes a major ... Building in Buffalo , as well ... manufacturing facility in Dunkirk . The ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... 12, 2016 , ... Atlantic Information Services, Inc. (AIS) is ... an upcoming Feb. 24 webinar that will discuss ways health plans and PBMs ... as the $1,000-per-pill hepatitis C treatment Sovaldi and high-cost PCSK9 inhibitors to treat ...
(Date:2/12/2016)... OBISPO, Calif. (PRWEB) , ... February 12, 2016 , ... The Central Coast Autism Spectrum ... this dance is to provide a night of fun for teens with and without special ... everyone feel welcomed and included at the event. The dance will take place on Saturday, ...
(Date:2/12/2016)... CA (PRWEB) , ... February 12, 2016 , ... With the exception of restorative dentistry, ... of dental decay. With the recent approval by the FDA, there is a now ... similar to fluoride varnish, SDF is very simple and quick to apply. The application ...
(Date:2/11/2016)... ... 2016 , ... SPH Analytics announced today that DeKalb ... solutions, MDinsight® and IndiGO®, for its primary care clinicians. The 3-year partnership brings ... contract were not disclosed. , As the healthcare market moves towards quality-based outcomes, ...
(Date:2/11/2016)... ... ... The Journal of Pain Research has seen a significant increase ... taken from the Scopus database (Elsevier B.V.) and is a measure of a journal's ... over a three year period and also the importance of the journals where the ...
Breaking Medicine News(10 mins):